LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation-Reference-Cited by-同舟云学术

LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation

Published:2023-11 Issue: Volume:576 Page:216420
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Lu,Sun Kangyue,Qin Wenjie,Huang Bing,Wu Changjie,Chen Junsheng,Lai Qiuhua,Wang Xinke,Zhou Rui,Li Aimin,Liu Side,Zhang Yue^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer treatment and survivorship statistics;Miller;CA Cancer J Clin,2022

3. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future;Vodenkova;Pharmacol. Ther.,2020

4. Metastatic colorectal cancer: advances in the folate-fluoropyrimidine chemotherapy backbone;Glimelius;Cancer Treat Rev.,2021

5. LIMK1/2 are required for actin filament and cell junction assembly in porcine embryos developing in vitro;Kwon;Asian-Australas. J. Anim. Sci.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the veil of RNA binding protein phase separation in cancer biology and therapy;Cancer Letters;2024-10

2. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer;International Immunopharmacology;2024-09

3. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB;Journal of Experimental & Clinical Cancer Research;2024-08-17

4. The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets;Clinical and Translational Medicine;2024-08

5. CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma;Cancer Letters;2024-07